{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:53:56Z","timestamp":1785884036799,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jhepr.2026.101845","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:02:43Z","timestamp":1775145763000},"page":"101845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zinc finger protein 544 promotes hepatocellular carcinoma by generating an immunosuppressive tumor microenvironment"],"prefix":"10.1016","volume":"8","author":[{"given":"Jie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101845_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhepr.2026.101845_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cytogfr.2024.08.006","article-title":"Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis","volume":"79","author":"Yu","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jhepr.2026.101845_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101845_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jhepr.2026.101845_bib5","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: from mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun"},{"key":"10.1016\/j.jhepr.2026.101845_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jhepr.2026.101845_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40364-021-00345-1","article-title":"Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma","volume":"10","author":"Li","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.jhepr.2026.101845_bib8","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1038\/s41598-023-30567-2","article-title":"Identification of a novel circRNA-miRNA-mRNA regulatory axis in hepatocellular carcinoma based on bioinformatics analysis","volume":"13","author":"Zhong","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.101845_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12876-022-02633-y","article-title":"SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma","volume":"23","author":"Lin","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101845_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710037","article-title":"Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells","volume":"23","author":"Fukushi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.101845_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-023-00612-x","article-title":"Newly discovered roles of triosephosphate isomerase including functions within the nucleus","volume":"29","author":"Myers","year":"2023","journal-title":"Mol Med"},{"key":"10.1016\/j.jhepr.2026.101845_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/JHC.S453249","article-title":"Single-cell RNA sequencing revealed that the enrichment of TPI1(+) malignant hepatocytes was linked to HCC metastasis and immunosuppressive microenvironment","volume":"11","author":"Liang","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.jhepr.2026.101845_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147915","article-title":"S-adenosylmethionine treatment affects histone methylation in prostate cancer cells","volume":"893","author":"Mathes","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.jhepr.2026.101845_bib14","doi-asserted-by":"crossref","first-page":"107666","DOI":"10.18632\/oncotarget.22587","article-title":"Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer","volume":"8","author":"Nambara","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2026.101845_bib15","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/hep.32062","article-title":"IL-1beta-induced elevation of solute carrier family 7 member 11 promotes hepatocellular carcinoma metastasis through up-regulating programmed death ligand 1 and colony-stimulating factor 1","volume":"74","author":"He","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101845_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.gastro.2024.02.025","article-title":"TGF-beta1-Induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD-L1 and CXCL12","volume":"167","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.101845_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s13167-024-00385-1","article-title":"Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches","volume":"15","author":"Li","year":"2024","journal-title":"EPMA J"},{"key":"10.1016\/j.jhepr.2026.101845_bib18","unstructured":"Gene Expression Profiling Interactive Analysis (GEPIA), http:\/\/gepia.cancer-pku.cn\/index.html."},{"key":"10.1016\/j.jhepr.2026.101845_bib19","unstructured":"UALCAN, https:\/\/ualcan.path.uab.edu\/index.html."},{"key":"10.1016\/j.jhepr.2026.101845_bib20","unstructured":"AnimalTFDB v4.0, https:\/\/guolab.wchscu.cn\/AnimalTFDB4\/#\/."},{"key":"10.1016\/j.jhepr.2026.101845_bib21","unstructured":"Sangerbox, http:\/\/vip.sangerbox.com."},{"key":"10.1016\/j.jhepr.2026.101845_bib22","unstructured":"Shiny Methylation Analysis Resource Tool, http:\/\/www.bioinfo-zs.com\/smartapp\/."},{"key":"10.1016\/j.jhepr.2026.101845_bib23","unstructured":"Cistrome Data Browser, https:\/\/db3.cistrome.org\/browser\/#\/."},{"key":"10.1016\/j.jhepr.2026.101845_bib24","unstructured":"RNAInter, http:\/\/www.rnainter.org\/."},{"key":"10.1016\/j.jhepr.2026.101845_bib25","unstructured":"PubChem, https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"10.1016\/j.jhepr.2026.101845_bib26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/17474124.2023.2279175","article-title":"Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis","volume":"17","author":"Li","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101845_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhepr.2026.101845_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41419-024-06888-z","article-title":"Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2026.101845_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1371089","article-title":"Immune regulation and therapeutic application of T regulatory cells in liver diseases","volume":"15","author":"Ajith","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.101845_bib30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhepr.2026.101845_bib31","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.18632\/aging.202281","article-title":"Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma","volume":"13","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jhepr.2026.101845_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7150\/jca.47526","article-title":"Inhibition of SPATS2 suppresses proliferation and invasion of hepatocellular carcinoma cells through TRIM44-STAT3 signaling pathway","volume":"12","author":"Chen","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.jhepr.2026.101845_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41419-020-03039-y","article-title":"SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2026.101845_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.semcancer.2022.03.025","article-title":"RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer","volume":"86","author":"Li","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jhepr.2026.101845_bib35","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.3390\/molecules28166163","article-title":"Human triosephosphate isomerase is a potential target in cancer due to commonly occurring post-translational modifications","volume":"28","author":"Enriquez-Flores","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jhepr.2026.101845_bib36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/2159-8290.CD-22-0805","article-title":"LKB1-dependent regulation of TPI1 creates a divergent metabolic liability between human and mouse lung adenocarcinoma","volume":"13","author":"Stein","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhepr.2026.101845_bib37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/biof.1826","article-title":"Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic\/gluconeogenic pathway through downregulation of TPI1","volume":"48","author":"Li","year":"2022","journal-title":"Biofactors"},{"key":"10.1016\/j.jhepr.2026.101845_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12967-022-03370-2","article-title":"TPI1 activates the PI3K\/AKT\/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5","volume":"20","author":"Jin","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.jhepr.2026.101845_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jhepr.2026.101845_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbcan.2017.04.002","article-title":"Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jhepr.2026.101845_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:36:30Z","timestamp":1785882990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589555926001163"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101845","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zinc finger protein 544 promotes hepatocellular carcinoma by generating an immunosuppressive tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101845"}}